The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Orally Disintegrating Tablet Technology Market Research Report 2025
Synopsis
Orally disintegrating tablet (ODT) technology involves the formulation of tablets that rapidly disintegrate and dissolve in the mouth without the need for water. This innovative pharmaceutical dosage form is designed to enhance patient convenience and compliance, particularly for individuals who have difficulty swallowing traditional tablets or capsules. ODTs typically utilize superdisintegrants, such as crospovidone or sodium starch glycolate, along with other excipients and processing techniques to promote rapid disintegration upon contact with saliva. The resulting tablet formulation provides a pleasant mouthfeel, quick dissolution, and improved bioavailability of the active pharmaceutical ingredient, making it suitable for various patient populations, including pediatric, geriatric, and psychiatric patients. Additionally, ODT technology offers advantages in terms of dosing accuracy, ease of administration, and potentially faster onset of action compared to conventional oral dosage forms.
The global Orally Disintegrating Tablet Technology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Orally Disintegrating Tablet Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Orally Disintegrating Tablet Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Orally Disintegrating Tablet Technology in Pharmaceutical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Orally Disintegrating Tablet Technology include Catalent, SPI Pharma, Takeda Pharmaceutical, Fuisz Technologies, Roquette, JRS Pharma, Fuji Chemical, Merck, Galvita, DAICEL, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Orally Disintegrating Tablet Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Disintegrating Tablet Technology.
The Orally Disintegrating Tablet Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Orally Disintegrating Tablet Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orally Disintegrating Tablet Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Catalent
SPI Pharma
Takeda Pharmaceutical
Fuisz Technologies
Roquette
JRS Pharma
Fuji Chemical
Merck
Galvita
DAICEL
BASF
Adare Pharma
Akina
Vitaquest
Segment by Type
Lyophilization
Compressed Tablets
Cotton candy Process
Segment by Application
Pharmaceutical
Nutraceuticals
Chewable Vitamin
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Orally Disintegrating Tablet Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Orally disintegrating tablet (ODT) technology involves the formulation of tablets that rapidly disintegrate and dissolve in the mouth without the need for water. This innovative pharmaceutical dosage form is designed to enhance patient convenience and compliance, particularly for individuals who have difficulty swallowing traditional tablets or capsules. ODTs typically utilize superdisintegrants, such as crospovidone or sodium starch glycolate, along with other excipients and processing techniques to promote rapid disintegration upon contact with saliva. The resulting tablet formulation provides a pleasant mouthfeel, quick dissolution, and improved bioavailability of the active pharmaceutical ingredient, making it suitable for various patient populations, including pediatric, geriatric, and psychiatric patients. Additionally, ODT technology offers advantages in terms of dosing accuracy, ease of administration, and potentially faster onset of action compared to conventional oral dosage forms.
The global Orally Disintegrating Tablet Technology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Orally Disintegrating Tablet Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Orally Disintegrating Tablet Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Orally Disintegrating Tablet Technology in Pharmaceutical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Orally Disintegrating Tablet Technology include Catalent, SPI Pharma, Takeda Pharmaceutical, Fuisz Technologies, Roquette, JRS Pharma, Fuji Chemical, Merck, Galvita, DAICEL, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Orally Disintegrating Tablet Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Disintegrating Tablet Technology.
The Orally Disintegrating Tablet Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Orally Disintegrating Tablet Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orally Disintegrating Tablet Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Catalent
SPI Pharma
Takeda Pharmaceutical
Fuisz Technologies
Roquette
JRS Pharma
Fuji Chemical
Merck
Galvita
DAICEL
BASF
Adare Pharma
Akina
Vitaquest
Segment by Type
Lyophilization
Compressed Tablets
Cotton candy Process
Segment by Application
Pharmaceutical
Nutraceuticals
Chewable Vitamin
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Orally Disintegrating Tablet Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Orally Disintegrating Tablet Technology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Lyophilization
1.2.3 Compressed Tablets
1.2.4 Cotton candy Process
1.3 Market by Application
1.3.1 Global Orally Disintegrating Tablet Technology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical
1.3.3 Nutraceuticals
1.3.4 Chewable Vitamin
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Orally Disintegrating Tablet Technology Market Perspective (2019-2030)
2.2 Global Orally Disintegrating Tablet Technology Growth Trends by Region
2.2.1 Global Orally Disintegrating Tablet Technology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Orally Disintegrating Tablet Technology Historic Market Size by Region (2019-2024)
2.2.3 Orally Disintegrating Tablet Technology Forecasted Market Size by Region (2025-2030)
2.3 Orally Disintegrating Tablet Technology Market Dynamics
2.3.1 Orally Disintegrating Tablet Technology Industry Trends
2.3.2 Orally Disintegrating Tablet Technology Market Drivers
2.3.3 Orally Disintegrating Tablet Technology Market Challenges
2.3.4 Orally Disintegrating Tablet Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Orally Disintegrating Tablet Technology Players by Revenue
3.1.1 Global Top Orally Disintegrating Tablet Technology Players by Revenue (2019-2024)
3.1.2 Global Orally Disintegrating Tablet Technology Revenue Market Share by Players (2019-2024)
3.2 Global Orally Disintegrating Tablet Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Orally Disintegrating Tablet Technology Revenue
3.4 Global Orally Disintegrating Tablet Technology Market Concentration Ratio
3.4.1 Global Orally Disintegrating Tablet Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Orally Disintegrating Tablet Technology Revenue in 2023
3.5 Global Key Players of Orally Disintegrating Tablet Technology Head office and Area Served
3.6 Global Key Players of Orally Disintegrating Tablet Technology, Product and Application
3.7 Global Key Players of Orally Disintegrating Tablet Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Orally Disintegrating Tablet Technology Breakdown Data by Type
4.1 Global Orally Disintegrating Tablet Technology Historic Market Size by Type (2019-2024)
4.2 Global Orally Disintegrating Tablet Technology Forecasted Market Size by Type (2025-2030)
5 Orally Disintegrating Tablet Technology Breakdown Data by Application
5.1 Global Orally Disintegrating Tablet Technology Historic Market Size by Application (2019-2024)
5.2 Global Orally Disintegrating Tablet Technology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Orally Disintegrating Tablet Technology Market Size (2019-2030)
6.2 North America Orally Disintegrating Tablet Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Orally Disintegrating Tablet Technology Market Size by Country (2019-2024)
6.4 North America Orally Disintegrating Tablet Technology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Orally Disintegrating Tablet Technology Market Size (2019-2030)
7.2 Europe Orally Disintegrating Tablet Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Orally Disintegrating Tablet Technology Market Size by Country (2019-2024)
7.4 Europe Orally Disintegrating Tablet Technology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Orally Disintegrating Tablet Technology Market Size (2019-2030)
8.2 Asia-Pacific Orally Disintegrating Tablet Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Orally Disintegrating Tablet Technology Market Size by Region (2019-2024)
8.4 Asia-Pacific Orally Disintegrating Tablet Technology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Orally Disintegrating Tablet Technology Market Size (2019-2030)
9.2 Latin America Orally Disintegrating Tablet Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Orally Disintegrating Tablet Technology Market Size by Country (2019-2024)
9.4 Latin America Orally Disintegrating Tablet Technology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Orally Disintegrating Tablet Technology Market Size (2019-2030)
10.2 Middle East & Africa Orally Disintegrating Tablet Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Orally Disintegrating Tablet Technology Market Size by Country (2019-2024)
10.4 Middle East & Africa Orally Disintegrating Tablet Technology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent Orally Disintegrating Tablet Technology Introduction
11.1.4 Catalent Revenue in Orally Disintegrating Tablet Technology Business (2019-2024)
11.1.5 Catalent Recent Development
11.2 SPI Pharma
11.2.1 SPI Pharma Company Details
11.2.2 SPI Pharma Business Overview
11.2.3 SPI Pharma Orally Disintegrating Tablet Technology Introduction
11.2.4 SPI Pharma Revenue in Orally Disintegrating Tablet Technology Business (2019-2024)
11.2.5 SPI Pharma Recent Development
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Company Details
11.3.2 Takeda Pharmaceutical Business Overview
11.3.3 Takeda Pharmaceutical Orally Disintegrating Tablet Technology Introduction
11.3.4 Takeda Pharmaceutical Revenue in Orally Disintegrating Tablet Technology Business (2019-2024)
11.3.5 Takeda Pharmaceutical Recent Development
11.4 Fuisz Technologies
11.4.1 Fuisz Technologies Company Details
11.4.2 Fuisz Technologies Business Overview
11.4.3 Fuisz Technologies Orally Disintegrating Tablet Technology Introduction
11.4.4 Fuisz Technologies Revenue in Orally Disintegrating Tablet Technology Business (2019-2024)
11.4.5 Fuisz Technologies Recent Development
11.5 Roquette
11.5.1 Roquette Company Details
11.5.2 Roquette Business Overview
11.5.3 Roquette Orally Disintegrating Tablet Technology Introduction
11.5.4 Roquette Revenue in Orally Disintegrating Tablet Technology Business (2019-2024)
11.5.5 Roquette Recent Development
11.6 JRS Pharma
11.6.1 JRS Pharma Company Details
11.6.2 JRS Pharma Business Overview
11.6.3 JRS Pharma Orally Disintegrating Tablet Technology Introduction
11.6.4 JRS Pharma Revenue in Orally Disintegrating Tablet Technology Business (2019-2024)
11.6.5 JRS Pharma Recent Development
11.7 Fuji Chemical
11.7.1 Fuji Chemical Company Details
11.7.2 Fuji Chemical Business Overview
11.7.3 Fuji Chemical Orally Disintegrating Tablet Technology Introduction
11.7.4 Fuji Chemical Revenue in Orally Disintegrating Tablet Technology Business (2019-2024)
11.7.5 Fuji Chemical Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Orally Disintegrating Tablet Technology Introduction
11.8.4 Merck Revenue in Orally Disintegrating Tablet Technology Business (2019-2024)
11.8.5 Merck Recent Development
11.9 Galvita
11.9.1 Galvita Company Details
11.9.2 Galvita Business Overview
11.9.3 Galvita Orally Disintegrating Tablet Technology Introduction
11.9.4 Galvita Revenue in Orally Disintegrating Tablet Technology Business (2019-2024)
11.9.5 Galvita Recent Development
11.10 DAICEL
11.10.1 DAICEL Company Details
11.10.2 DAICEL Business Overview
11.10.3 DAICEL Orally Disintegrating Tablet Technology Introduction
11.10.4 DAICEL Revenue in Orally Disintegrating Tablet Technology Business (2019-2024)
11.10.5 DAICEL Recent Development
11.11 BASF
11.11.1 BASF Company Details
11.11.2 BASF Business Overview
11.11.3 BASF Orally Disintegrating Tablet Technology Introduction
11.11.4 BASF Revenue in Orally Disintegrating Tablet Technology Business (2019-2024)
11.11.5 BASF Recent Development
11.12 Adare Pharma
11.12.1 Adare Pharma Company Details
11.12.2 Adare Pharma Business Overview
11.12.3 Adare Pharma Orally Disintegrating Tablet Technology Introduction
11.12.4 Adare Pharma Revenue in Orally Disintegrating Tablet Technology Business (2019-2024)
11.12.5 Adare Pharma Recent Development
11.13 Akina
11.13.1 Akina Company Details
11.13.2 Akina Business Overview
11.13.3 Akina Orally Disintegrating Tablet Technology Introduction
11.13.4 Akina Revenue in Orally Disintegrating Tablet Technology Business (2019-2024)
11.13.5 Akina Recent Development
11.14 Vitaquest
11.14.1 Vitaquest Company Details
11.14.2 Vitaquest Business Overview
11.14.3 Vitaquest Orally Disintegrating Tablet Technology Introduction
11.14.4 Vitaquest Revenue in Orally Disintegrating Tablet Technology Business (2019-2024)
11.14.5 Vitaquest Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Orally Disintegrating Tablet Technology Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Lyophilization
Table 3. Key Players of Compressed Tablets
Table 4. Key Players of Cotton candy Process
Table 5. Global Orally Disintegrating Tablet Technology Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Orally Disintegrating Tablet Technology Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Orally Disintegrating Tablet Technology Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Orally Disintegrating Tablet Technology Market Share by Region (2019-2024)
Table 9. Global Orally Disintegrating Tablet Technology Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Orally Disintegrating Tablet Technology Market Share by Region (2025-2030)
Table 11. Orally Disintegrating Tablet Technology Market Trends
Table 12. Orally Disintegrating Tablet Technology Market Drivers
Table 13. Orally Disintegrating Tablet Technology Market Challenges
Table 14. Orally Disintegrating Tablet Technology Market Restraints
Table 15. Global Orally Disintegrating Tablet Technology Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Orally Disintegrating Tablet Technology Market Share by Players (2019-2024)
Table 17. Global Top Orally Disintegrating Tablet Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Tablet Technology as of 2023)
Table 18. Ranking of Global Top Orally Disintegrating Tablet Technology Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Orally Disintegrating Tablet Technology Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Orally Disintegrating Tablet Technology, Headquarters and Area Served
Table 21. Global Key Players of Orally Disintegrating Tablet Technology, Product and Application
Table 22. Global Key Players of Orally Disintegrating Tablet Technology, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Orally Disintegrating Tablet Technology Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Orally Disintegrating Tablet Technology Revenue Market Share by Type (2019-2024)
Table 26. Global Orally Disintegrating Tablet Technology Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Orally Disintegrating Tablet Technology Revenue Market Share by Type (2025-2030)
Table 28. Global Orally Disintegrating Tablet Technology Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Orally Disintegrating Tablet Technology Revenue Market Share by Application (2019-2024)
Table 30. Global Orally Disintegrating Tablet Technology Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Orally Disintegrating Tablet Technology Revenue Market Share by Application (2025-2030)
Table 32. North America Orally Disintegrating Tablet Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Orally Disintegrating Tablet Technology Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Orally Disintegrating Tablet Technology Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Orally Disintegrating Tablet Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Orally Disintegrating Tablet Technology Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Orally Disintegrating Tablet Technology Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Orally Disintegrating Tablet Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Orally Disintegrating Tablet Technology Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Orally Disintegrating Tablet Technology Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Orally Disintegrating Tablet Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Orally Disintegrating Tablet Technology Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Orally Disintegrating Tablet Technology Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Orally Disintegrating Tablet Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Orally Disintegrating Tablet Technology Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Orally Disintegrating Tablet Technology Market Size by Country (2025-2030) & (US$ Million)
Table 47. Catalent Company Details
Table 48. Catalent Business Overview
Table 49. Catalent Orally Disintegrating Tablet Technology Product
Table 50. Catalent Revenue in Orally Disintegrating Tablet Technology Business (2019-2024) & (US$ Million)
Table 51. Catalent Recent Development
Table 52. SPI Pharma Company Details
Table 53. SPI Pharma Business Overview
Table 54. SPI Pharma Orally Disintegrating Tablet Technology Product
Table 55. SPI Pharma Revenue in Orally Disintegrating Tablet Technology Business (2019-2024) & (US$ Million)
Table 56. SPI Pharma Recent Development
Table 57. Takeda Pharmaceutical Company Details
Table 58. Takeda Pharmaceutical Business Overview
Table 59. Takeda Pharmaceutical Orally Disintegrating Tablet Technology Product
Table 60. Takeda Pharmaceutical Revenue in Orally Disintegrating Tablet Technology Business (2019-2024) & (US$ Million)
Table 61. Takeda Pharmaceutical Recent Development
Table 62. Fuisz Technologies Company Details
Table 63. Fuisz Technologies Business Overview
Table 64. Fuisz Technologies Orally Disintegrating Tablet Technology Product
Table 65. Fuisz Technologies Revenue in Orally Disintegrating Tablet Technology Business (2019-2024) & (US$ Million)
Table 66. Fuisz Technologies Recent Development
Table 67. Roquette Company Details
Table 68. Roquette Business Overview
Table 69. Roquette Orally Disintegrating Tablet Technology Product
Table 70. Roquette Revenue in Orally Disintegrating Tablet Technology Business (2019-2024) & (US$ Million)
Table 71. Roquette Recent Development
Table 72. JRS Pharma Company Details
Table 73. JRS Pharma Business Overview
Table 74. JRS Pharma Orally Disintegrating Tablet Technology Product
Table 75. JRS Pharma Revenue in Orally Disintegrating Tablet Technology Business (2019-2024) & (US$ Million)
Table 76. JRS Pharma Recent Development
Table 77. Fuji Chemical Company Details
Table 78. Fuji Chemical Business Overview
Table 79. Fuji Chemical Orally Disintegrating Tablet Technology Product
Table 80. Fuji Chemical Revenue in Orally Disintegrating Tablet Technology Business (2019-2024) & (US$ Million)
Table 81. Fuji Chemical Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Orally Disintegrating Tablet Technology Product
Table 85. Merck Revenue in Orally Disintegrating Tablet Technology Business (2019-2024) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Galvita Company Details
Table 88. Galvita Business Overview
Table 89. Galvita Orally Disintegrating Tablet Technology Product
Table 90. Galvita Revenue in Orally Disintegrating Tablet Technology Business (2019-2024) & (US$ Million)
Table 91. Galvita Recent Development
Table 92. DAICEL Company Details
Table 93. DAICEL Business Overview
Table 94. DAICEL Orally Disintegrating Tablet Technology Product
Table 95. DAICEL Revenue in Orally Disintegrating Tablet Technology Business (2019-2024) & (US$ Million)
Table 96. DAICEL Recent Development
Table 97. BASF Company Details
Table 98. BASF Business Overview
Table 99. BASF Orally Disintegrating Tablet Technology Product
Table 100. BASF Revenue in Orally Disintegrating Tablet Technology Business (2019-2024) & (US$ Million)
Table 101. BASF Recent Development
Table 102. Adare Pharma Company Details
Table 103. Adare Pharma Business Overview
Table 104. Adare Pharma Orally Disintegrating Tablet Technology Product
Table 105. Adare Pharma Revenue in Orally Disintegrating Tablet Technology Business (2019-2024) & (US$ Million)
Table 106. Adare Pharma Recent Development
Table 107. Akina Company Details
Table 108. Akina Business Overview
Table 109. Akina Orally Disintegrating Tablet Technology Product
Table 110. Akina Revenue in Orally Disintegrating Tablet Technology Business (2019-2024) & (US$ Million)
Table 111. Akina Recent Development
Table 112. Vitaquest Company Details
Table 113. Vitaquest Business Overview
Table 114. Vitaquest Orally Disintegrating Tablet Technology Product
Table 115. Vitaquest Revenue in Orally Disintegrating Tablet Technology Business (2019-2024) & (US$ Million)
Table 116. Vitaquest Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
Table 120. Authors List of This Report
List of Figures
Figure 1. Orally Disintegrating Tablet Technology Picture
Figure 2. Global Orally Disintegrating Tablet Technology Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Orally Disintegrating Tablet Technology Market Share by Type: 2023 VS 2030
Figure 4. Lyophilization Features
Figure 5. Compressed Tablets Features
Figure 6. Cotton candy Process Features
Figure 7. Global Orally Disintegrating Tablet Technology Market Size by Application (2024-2030) & (US$ Million)
Figure 8. Global Orally Disintegrating Tablet Technology Market Share by Application: 2023 VS 2030
Figure 9. Pharmaceutical Case Studies
Figure 10. Nutraceuticals Case Studies
Figure 11. Chewable Vitamin Case Studies
Figure 12. Orally Disintegrating Tablet Technology Report Years Considered
Figure 13. Global Orally Disintegrating Tablet Technology Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Orally Disintegrating Tablet Technology Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Orally Disintegrating Tablet Technology Market Share by Region: 2023 VS 2030
Figure 16. Global Orally Disintegrating Tablet Technology Market Share by Players in 2023
Figure 17. Global Top Orally Disintegrating Tablet Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Tablet Technology as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Orally Disintegrating Tablet Technology Revenue in 2023
Figure 19. North America Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Orally Disintegrating Tablet Technology Market Share by Country (2019-2030)
Figure 21. United States Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Orally Disintegrating Tablet Technology Market Share by Country (2019-2030)
Figure 25. Germany Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Orally Disintegrating Tablet Technology Market Share by Region (2019-2030)
Figure 33. China Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Orally Disintegrating Tablet Technology Market Share by Country (2019-2030)
Figure 41. Mexico Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Orally Disintegrating Tablet Technology Market Share by Country (2019-2030)
Figure 45. Turkey Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. UAE Orally Disintegrating Tablet Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Catalent Revenue Growth Rate in Orally Disintegrating Tablet Technology Business (2019-2024)
Figure 49. SPI Pharma Revenue Growth Rate in Orally Disintegrating Tablet Technology Business (2019-2024)
Figure 50. Takeda Pharmaceutical Revenue Growth Rate in Orally Disintegrating Tablet Technology Business (2019-2024)
Figure 51. Fuisz Technologies Revenue Growth Rate in Orally Disintegrating Tablet Technology Business (2019-2024)
Figure 52. Roquette Revenue Growth Rate in Orally Disintegrating Tablet Technology Business (2019-2024)
Figure 53. JRS Pharma Revenue Growth Rate in Orally Disintegrating Tablet Technology Business (2019-2024)
Figure 54. Fuji Chemical Revenue Growth Rate in Orally Disintegrating Tablet Technology Business (2019-2024)
Figure 55. Merck Revenue Growth Rate in Orally Disintegrating Tablet Technology Business (2019-2024)
Figure 56. Galvita Revenue Growth Rate in Orally Disintegrating Tablet Technology Business (2019-2024)
Figure 57. DAICEL Revenue Growth Rate in Orally Disintegrating Tablet Technology Business (2019-2024)
Figure 58. BASF Revenue Growth Rate in Orally Disintegrating Tablet Technology Business (2019-2024)
Figure 59. Adare Pharma Revenue Growth Rate in Orally Disintegrating Tablet Technology Business (2019-2024)
Figure 60. Akina Revenue Growth Rate in Orally Disintegrating Tablet Technology Business (2019-2024)
Figure 61. Vitaquest Revenue Growth Rate in Orally Disintegrating Tablet Technology Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
